Annual Retained Earnings
-$309.32 M
-$18.35 M-6.31%
December 31, 2023
Summary
- As of March 10, 2025, TOVX annual retained earnings is -$309.32 million, with the most recent change of -$18.35 million (-6.31%) on December 31, 2023.
- During the last 3 years, TOVX annual retained earnings has fallen by -$61.22 million (-24.68%).
- TOVX annual retained earnings is now -7802.26% below its all-time high of -$3.91 million, reached on December 1, 2005.
Performance
TOVX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$330.52 M
-$7.73 M-2.39%
September 30, 2024
Summary
- As of March 10, 2025, TOVX quarterly retained earnings is -$330.52 million, with the most recent change of -$7.73 million (-2.39%) on September 30, 2024.
- Over the past year, TOVX quarterly retained earnings has stayed the same.
- TOVX quarterly retained earnings is now -1612217.07% below its all-time high of -$20.50 thousand, reached on March 1, 2006.
Performance
TOVX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TOVX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.3% | 0.0% |
| 3 y3 years | -24.7% | 0.0% |
| 5 y5 years | -40.9% | 0.0% |
TOVX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.0% | at low | -19.9% | at low |
| 5 y | 5-year | -31.3% | at low | -38.3% | at low |
| alltime | all time | -7802.3% | at low | <-9999.0% | at low |
Theriva Biologics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$330.52 M(+2.4%) |
| Jun 2024 | - | -$322.80 M(+2.6%) |
| Mar 2024 | - | -$314.48 M(+1.7%) |
| Dec 2023 | -$309.32 M(+6.3%) | -$309.32 M(+1.8%) |
| Sep 2023 | - | -$303.83 M(+1.1%) |
| Jun 2023 | - | -$300.53 M(+1.7%) |
| Mar 2023 | - | -$295.45 M(+1.5%) |
| Dec 2022 | -$290.97 M(+7.3%) | -$290.97 M(+2.0%) |
| Sep 2022 | - | -$285.38 M(+1.7%) |
| Jun 2022 | - | -$280.52 M(+1.8%) |
| Mar 2022 | - | -$275.56 M(+1.6%) |
| Dec 2021 | -$271.28 M(+9.3%) | - |
| Dec 2021 | - | -$271.28 M(+2.0%) |
| Sep 2021 | - | -$266.02 M(+1.2%) |
| Jun 2021 | - | -$262.75 M(+1.2%) |
| Mar 2021 | - | -$259.55 M(+4.6%) |
| Dec 2020 | -$248.09 M(+5.3%) | -$248.09 M(+1.3%) |
| Sep 2020 | - | -$244.97 M(+1.1%) |
| Jun 2020 | - | -$242.29 M(+1.4%) |
| Mar 2020 | - | -$238.97 M(+1.5%) |
| Dec 2019 | -$235.54 M(+7.3%) | -$235.54 M(+1.4%) |
| Sep 2019 | - | -$232.39 M(+2.3%) |
| Jun 2019 | - | -$227.14 M(+1.7%) |
| Mar 2019 | - | -$223.43 M(+1.8%) |
| Dec 2018 | -$219.46 M(+13.0%) | -$219.46 M(+7.3%) |
| Sep 2018 | - | -$204.54 M(+1.9%) |
| Jun 2018 | - | -$200.80 M(+2.2%) |
| Mar 2018 | - | -$196.54 M(+1.2%) |
| Dec 2017 | -$194.17 M(+12.9%) | -$194.17 M(-1.4%) |
| Sep 2017 | - | -$196.96 M(+10.0%) |
| Jun 2017 | - | -$179.13 M(+2.4%) |
| Mar 2017 | - | -$174.88 M(+1.7%) |
| Dec 2016 | -$172.03 M(+18.8%) | -$172.03 M(+1.4%) |
| Sep 2016 | - | -$169.66 M(+5.2%) |
| Jun 2016 | - | -$161.31 M(+3.7%) |
| Mar 2016 | - | -$155.62 M(+7.5%) |
| Dec 2015 | -$144.78 M(+43.3%) | -$144.78 M(+8.2%) |
| Sep 2015 | - | -$133.80 M(+5.3%) |
| Jun 2015 | - | -$127.02 M(+12.0%) |
| Mar 2015 | - | -$113.40 M(+12.2%) |
| Dec 2014 | -$101.04 M(+24.3%) | -$101.04 M(+6.9%) |
| Sep 2014 | - | -$94.56 M(+5.5%) |
| Jun 2014 | - | -$89.65 M(+5.4%) |
| Mar 2014 | - | -$85.10 M(+4.7%) |
| Dec 2013 | -$81.26 M(+17.9%) | -$81.26 M(+5.5%) |
| Sep 2013 | - | -$77.03 M(+4.6%) |
| Jun 2013 | - | -$73.67 M(+3.5%) |
| Mar 2013 | - | -$71.17 M(+3.2%) |
| Dec 2012 | -$68.94 M(+32.9%) | -$68.94 M(+21.2%) |
| Sep 2012 | - | -$56.88 M(+3.5%) |
| Jun 2012 | - | -$54.95 M(+3.5%) |
| Mar 2012 | - | -$53.07 M(+2.3%) |
| Dec 2011 | -$51.87 M(+18.6%) | -$51.87 M(+6.5%) |
| Sep 2011 | - | -$48.69 M(+2.3%) |
| Jun 2011 | - | -$47.59 M(+3.7%) |
| Mar 2011 | - | -$45.91 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | -$43.72 M(+4.1%) | -$43.72 M(+2.0%) |
| Sep 2010 | - | -$42.85 M(+1.7%) |
| Jun 2010 | - | -$42.12 M(-2.3%) |
| Mar 2010 | - | -$43.10 M(+2.6%) |
| Dec 2009 | -$42.01 M(+9.7%) | -$42.01 M(+2.7%) |
| Sep 2009 | - | -$40.90 M(+1.6%) |
| Jun 2009 | - | -$40.27 M(+2.2%) |
| Mar 2009 | - | -$39.40 M(+2.9%) |
| Dec 2008 | -$38.28 M(+23.2%) | -$38.28 M(+2.4%) |
| Sep 2008 | - | -$37.37 M(+4.0%) |
| Jun 2008 | - | -$35.94 M(+5.2%) |
| Mar 2008 | - | -$34.17 M(+9.9%) |
| Dec 2007 | -$31.08 M(+254.2%) | -$31.08 M(+11.3%) |
| Sep 2007 | - | -$27.92 M(+8.2%) |
| Jun 2007 | - | -$25.80 M(+7.3%) |
| Mar 2007 | - | -$24.03 M(+173.9%) |
| Dec 2006 | -$8.77 M(+124.2%) | -$8.77 M(>+9900.0%) |
| Sep 2006 | - | -$27.90 K(+36.1%) |
| Mar 2006 | - | -$20.50 K(-100.0%) |
| Dec 2005 | -$3.91 M(-96.2%) | - |
| Mar 2003 | - | -$104.60 M(+1.1%) |
| Dec 2002 | -$103.44 M(+11.8%) | -$103.44 M(+1.9%) |
| Sep 2002 | - | -$101.50 M(+1.6%) |
| Jun 2002 | - | -$99.93 M(+4.2%) |
| Mar 2002 | - | -$95.89 M(+3.7%) |
| Dec 2001 | -$92.50 M(+14.2%) | -$92.50 M(+4.3%) |
| Sep 2001 | - | -$88.66 M(+3.3%) |
| Jun 2001 | - | -$85.82 M(+3.7%) |
| Mar 2001 | - | -$82.79 M(+2.2%) |
| Dec 2000 | -$80.97 M(+10.3%) | -$80.97 M(+2.9%) |
| Sep 2000 | - | -$78.68 M(+2.0%) |
| Jun 2000 | - | -$77.13 M(+2.7%) |
| Mar 2000 | - | -$75.09 M(+2.3%) |
| Dec 1999 | -$73.41 M(+33.0%) | -$73.41 M(+22.6%) |
| Sep 1999 | - | -$59.90 M(+2.9%) |
| Jun 1999 | - | -$58.20 M(+3.0%) |
| Mar 1999 | - | -$56.50 M(+2.4%) |
| Dec 1998 | -$55.20 M(+52.5%) | -$55.20 M(+2.4%) |
| Sep 1998 | - | -$53.90 M(+4.3%) |
| Jun 1998 | - | -$51.70 M(+34.6%) |
| Mar 1998 | - | -$38.40 M(+6.1%) |
| Dec 1997 | -$36.20 M(+36.1%) | -$36.20 M(+4.3%) |
| Sep 1997 | - | -$34.70 M(+5.8%) |
| Jun 1997 | - | -$32.80 M(+11.9%) |
| Mar 1997 | - | -$29.30 M(+10.2%) |
| Dec 1996 | -$26.60 M(+35.7%) | -$26.60 M(+8.6%) |
| Sep 1996 | - | -$24.50 M(+7.0%) |
| Jun 1996 | - | -$22.90 M(+8.0%) |
| Mar 1996 | - | -$21.20 M(+8.2%) |
| Dec 1995 | -$19.60 M(+60.7%) | -$19.60 M(+11.4%) |
| Sep 1995 | - | -$17.60 M(+44.3%) |
| Dec 1994 | -$12.20 M(+106.8%) | -$12.20 M(+93.7%) |
| Mar 1994 | - | -$6.30 M(+6.8%) |
| Dec 1993 | -$5.90 M | -$5.90 M(+34.1%) |
| Sep 1993 | - | -$4.40 M(+46.7%) |
| Jun 1993 | - | -$3.00 M(+25.0%) |
| Mar 1993 | - | -$2.40 M |
FAQ
- What is Theriva Biologics annual retained earnings?
- What is the all time high annual retained earnings for Theriva Biologics?
- What is Theriva Biologics annual retained earnings year-on-year change?
- What is Theriva Biologics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Theriva Biologics?
- What is Theriva Biologics quarterly retained earnings year-on-year change?
What is Theriva Biologics annual retained earnings?
The current annual retained earnings of TOVX is -$309.32 M
What is the all time high annual retained earnings for Theriva Biologics?
Theriva Biologics all-time high annual retained earnings is -$3.91 M
What is Theriva Biologics annual retained earnings year-on-year change?
Over the past year, TOVX annual retained earnings has changed by -$18.35 M (-6.31%)
What is Theriva Biologics quarterly retained earnings?
The current quarterly retained earnings of TOVX is -$330.52 M
What is the all time high quarterly retained earnings for Theriva Biologics?
Theriva Biologics all-time high quarterly retained earnings is -$20.50 K
What is Theriva Biologics quarterly retained earnings year-on-year change?
Over the past year, TOVX quarterly retained earnings has changed by $0.00 (0.00%)